FDA greenlights Italfarmaco's drug for rare muscular dystrophy-March 2024-www.financetom.com

FDA greenlights Italfarmaco's drug for rare muscular dystrophy

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

FDA greenlights Italfarmaco's drug for rare muscular dystrophy

Mar 21, 2024 3:56 PM

March 21 (Reuters) - The U.S. FDA has approved privately

held Italfarmaco Group's drug to treat Duchenne muscular

dystrophy (DMD), an inherited muscle-wasting disorder, the

health regulator said on Thursday.

Previous page： Microsoft launches AI labs with 10 colleges in India Next page： Apple mulling to buy Intel's modem business

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Microsoft launches AI labs with 10 colleges in India

Jun 13, 2019

The programme, 'Intelligent Cloud Hub', covers institutes including BITS Pilani, SRM Institute of Science and Technology and Trident Academy of Technology among others.

Apple mulling to buy Intel's modem business

Jun 13, 2019

Apple is reportedly looking to buy Intel's modem division since last year but could not strike a deal.

In pictures: First glimpse of ISRO's Chandrayaan-2

Jun 13, 2019

The Indian Space Research Organisation (ISRO) is all set to launch Chandrayaan-2 to the Moon. Expected to be launched next month, the lunar mission is aiming to reach the south pole of the Moon, a feat never achieved before by anyone. Here is a look at some images released by the agency showing Chandrayaan-2.

Government plans 50-100% subsidy for electric vehicle charging infrastructure

Jun 13, 2019

The Narendra Modi government is mulling a 50 to 100 percent subsidy to electric vehicle charging infrastructure.